Comparing drug effectiveness at health plans: the ethics of cluster randomized trials
dc.contributor.author | Sabin, James E. | |
dc.contributor.author | Mazor, Kathleen M. | |
dc.contributor.author | Meterko, Vanessa | |
dc.contributor.author | Goff, Sarah L. | |
dc.contributor.author | Platt, Richard | |
dc.date | 2022-08-11T08:09:22.000 | |
dc.date.accessioned | 2022-08-23T16:28:37Z | |
dc.date.available | 2022-08-23T16:28:37Z | |
dc.date.issued | 2008-10-25 | |
dc.date.submitted | 2011-12-30 | |
dc.identifier.citation | Hastings Cent Rep. 2008 Sep-Oct;38(5):39-48. <a href="http://www.jstor.org/stable/25165369">Link to article on publisher's website</a> | |
dc.identifier.issn | 0093-0334 (Linking) | |
dc.identifier.pmid | 18947140 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/37057 | |
dc.description.abstract | "Cluster randomized trials," in which groups of patients are randomly assigned to different therapeutic interventions, provide a powerful way of evaluating drugs. CRTs have not been widely used, in good part because of concerns about whether patients must give informed consent to participate in them. A better understanding of how CRTs fit into clinical practice resolves the concerns. | |
dc.language.iso | en_US | |
dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=18947140&dopt=Abstract">Link to Article in PubMed</a> | |
dc.relation.url | http://www.jstor.org/stable/25165369 | |
dc.subject | *Cluster Analysis | |
dc.subject | Data Collection | |
dc.subject | Health Facility Administrators | |
dc.subject | Humans | |
dc.subject | Informed Consent | |
dc.subject | Patient Satisfaction | |
dc.subject | Randomized Controlled Trials as Topic | |
dc.subject | Health Services Research | |
dc.subject | Primary Care | |
dc.title | Comparing drug effectiveness at health plans: the ethics of cluster randomized trials | |
dc.type | Journal Article | |
dc.source.journaltitle | The Hastings Center report | |
dc.source.volume | 38 | |
dc.source.issue | 5 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/meyers_pp/441 | |
dc.identifier.contextkey | 2426097 | |
html.description.abstract | <p>"Cluster randomized trials," in which groups of patients are randomly assigned to different therapeutic interventions, provide a powerful way of evaluating drugs. CRTs have not been widely used, in good part because of concerns about whether patients must give informed consent to participate in them. A better understanding of how CRTs fit into clinical practice resolves the concerns.</p> | |
dc.identifier.submissionpath | meyers_pp/441 | |
dc.contributor.department | Meyers Primary Care Institute | |
dc.source.pages | 39-48 |